Mediators of Inflammation / 2013 / Article / Tab 1

Clinical Study

Expression of Inflammation-Related Genes Is Altered in Gastric Tissue of Patients with Advanced Stages of NAFLD

Table 1

Demographic and clinical characteristics of the patient cohorts profiled for expression of inflammation- and immunity-related genes, values marked by asterisk ( ) are given as average ± SD. All subjects qualified for NAFLD had no history of alcohol abuse. No patients were taking thiazolidinediones (TZDs) or medication for gastritis.

Demographic or clinical parameterMean ± SD, or % ( )

BMI ( )48.67 ± 8.95
AST, U/L ( )24.20 ± 7.13
ALT, U/L ( )31.25 ± 12.99
Total cholesterol, mg/dL ( )185.40 ± 76.61
HDL, mg/dL ( ) females53 ± 17
HDL, mg/dL ( ) males39.67 ± 7.09
Triglyceride, mg/dL ( )196.75 ± 107.28
Glucose, mg/dL ( )108.70 ± 36.20
Age, yr43.44 ± 10.63
Hypertension55% ( )
Smoking5% ( )
Gender (females)75% ( )
Race (Caucasian)80% ( )
Advanced inflammation (score ≥ 3)50% ( )
NASH65% ( )
Advanced steatosis60% ( )
Fibrosis75% ( )
Steatosis with advanced inflammation50% ( )
NASH with advanced inflammation30% ( )
Gastritis45% ( )

SD: standard deviation; BMI: body mass index; NASH: nonalcoholic steatohepatitis; AST: aspartate aminotransferase; ALT: alanine transaminase; HDL: high-density lipoprotein.